Questionnaire Editor

UTI - Urinary Tract Infection (Pharmacy First)

Keep focus on the canvas. Use the right panel for detail work and templates for repeatable patterns.

25 nodes 24 edges
No selection
Workspace Drag to move nodes. Scroll to zoom. Hold Shift to multi-select.
100%
>=1>=10>=10>=10>=1No symptom1 symptom2 or 3 symptoms0>=1mild0>=1severesepsis_signs00
Question

Check nitrofurantoin eligibility, Select ALL that apply. If none apply, select "none apply".

node_1773814310495 select_multiple
Info

For patients presenting with symptoms of uncomplicated urinary tract infection

intro_guidance info_panel info
Question

Consider the risk of deterioration, red flags or serious illness. Select ANY that apply.

sepsis_screen decision select_multiple
Referral

Consider calculating NEWS2 Score ahead of signposting patient to A&E or calling 999 in a life threatening emergency.

outcome_emergency referral info
Question

Check for any new signs/symptoms of pyelonephritis, Select ANY that apply.

pyelonephritis_check decision select_multiple
Referral

Urgent same day referral • General practice • Relevant out of hours service

outcome_pyelonephritis_referral referral info
Question

Does the patient have any of the following, Select ANY that apply.

exclusions_check decision select_multiple
Referral

Onward referral • General practice • Sexual health clinics • Other provider as appropriate

outcome_exclusion_referral referral info
Question

Does the patient have any of the 3 key diagnostic signs/symptoms: Dysuria (Acute pain or burning sensation when passing urine or at the end of urination) New nocturia (needing to pass urine in the night) Urine cloudy to the naked eye (visual inspection by pharmacist if practicable)

gateway_diagnostic decision select_multiple
Question

Are there other urinary symptoms? Select ANY that apply.

other_urinary_symptoms decision select_multiple
Info

UTI equally likely to other diagnosis

uti_equally_likely info_panel info
Question

Shared decision making approach using TARGET UTI resources

treatment_2_or_3 info_panel select
Outcome

UTI less likely

outcome_uti_less_likely outcome info
Outcome

Self-care and pain relief

outcome_self_care_pain_relief outcome info
Outcome

In patients that describe their symptoms as mild consider pain relief and self care as first line treatment Ask patient to return to Pharmacy if no improvement in 48 hours for pharmacist reassessment

outcome_mild_self_care outcome info
Outcome

In patients with moderate to severe symptoms, offer nitrofurantoin for 3 days (subject to inclusion/exclusion criteria in PGD) plus self-care

outcome_treat_nitrofurantoin outcome info
Referral

• General Practice • Sexual heath clinics • Other provider as appropriate

outcome_pgd_referral referral info
Question

Is the patient eligible for this pathway? Select ANY that apply.

node_1773703693667 select_multiple
Referral

Patient not eligible for this pathway. Refer to prescriber or appropriate service.

node_1773703900610 info
Info

UTI equally likely to other diagnosis

uti_equally_likely_copy_1773705009755_0 info
Referral

• General Practice • Sexual heath clinics • Other provider as appropriate

outcome_pgd_referral_copy_1773705010014_1 info
Referral

Urgent A&E referral via ambulance for suspected sepsis

node_1773814241455 select
Question

Concurrent medication for nitrofurantonin. Select ALL that apply. If none apply, select "none apply". Select ALL that apply. If none apply, select "none apply".

node_1773814310495_copy_1773818306827_0 select_multiple
Referral

Patient falls under aciclovir PGD exclusion criteria. Onward referral — General practice or other provider as appropriate.

node_1773820138416 select
Referral

Patient falls under aciclovir PGD exclusion criteria. Onward referral — General practice or other provider as appropriate.

node_1773820138416_copy_1773820164009_0 select

Questionnaire Editor

Questionnaire details

Active

Keep the core metadata tight and scan-friendly. Less common content sits in its own section.

Record settings Save after changing metadata or publishing state.